Rankings
▼
Calendar
LNTH
Lantheus Holdings, Inc.
$5B
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$74M
Gross Profit
$35M
46.6% margin
Operating Income
$12M
16.3% margin
Net Income
$5M
6.5% margin
EPS (Diluted)
$0.13
QoQ Revenue Growth
+1.8%
Cash Flow
Operating Cash Flow
$13M
Free Cash Flow
$10M
Stock-Based Comp.
$655,000
Balance Sheet
Total Assets
$256M
Total Liabilities
$362M
Stockholders' Equity
-$107M
Cash & Equivalents
$51M
Revenue Segments
US Segment
$65M
87%
International Segment
$10M
13%
← FY 2016
All Quarters
Q1 2017 →
LNTH Q4 2016 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena